Pasar al contenido principal

INTERVENCIONES CON POLIFENOLES DE LA DIETA DIRIGIDAS AL MICROBIOMA Y EL EJE ORAL-INTESTINO-CEREBRO EN EL RIESGO Y PROGRESION DE LA ENFERMEDAD DE ALZHEIMER Y SALUD COGNITIVA

PID2023-148419OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiome and clinical and lifestyle host factors associated with recurrent positive RT-PCR for SARS-CoV-2

  • Jiménez Arroyo, Cristina
  • Molinero, Natalia
  • Sabater, Carlos
  • Margolles Barros, Abelardo
  • Terrón-Camero, Laura Carmen
  • Andrés-León, Eduardo
  • Ramos, Manuel
  • Val, Margarita del
  • Moreno-Arribas, M. Victoria
The data presented in the study are deposited in the Sequence Read Archive (SRA) repository, accession number PRJNA1099539, SARS-CoV-2 and COVID-19 are still active in the population. Some patients remained PCR-positive for more than 4 weeks, called "persistently PCR-positive". Recent evidence suggests a link between the gut microbiota and susceptibility to COVID-19, although no studies have explored persistent PCR conditions. We aimed to evaluate the relationship between persistent positive SARS-CoV-2 RT-PCR, the gut microbiome, and individual host determinants., This research was funded by SGL2021-03-056 (CSIC Interdisciplinary Thematic Platform on Global Health) and PID2023-148419OB-I00 (MICIU)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Desarrollo de snacks a partir de residuos vegetales de desperdicio alimentario: impacto en la microbiota intestinal

  • Chagas, E.G.L.
  • Relaño de la Guía, Edgard
  • Molinero, Natalia
  • Tamargo, Alba
  • Carvalho, R. A.
  • Moreno-Arribas, M. Victoria
  • González de Llano, Dolores
Póster presentado al XVI Congreso de la Sociedad Española de Microbiota Probióticos y Prebióticos (SEMiPyP), celebrado en Barcelona del 19 al 21 de febrero de 2025., Financiación del Ministerio de Ciencia, Innovación y Universidades (proyecto PID2023-148419OB-100), y de la Fundación de Apoyo a la Investigación Científica del Estado de São Paulo (FAPESP Nº2019/13944-3). EGLC fue financiado por la Coordinación para el Perfeccionamineto del personal de la Enseñanaza Superior - Brasil (CAPES 001) y DGDL Fundación Carolina-CSIC., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

May sulfites in wine affect gut microbiota? An in vitro study of their digestion and interplay with wine polyphenols

  • Relaño de la Guía, Edgard
  • Cueva, Carolina
  • Molinero, Natalia
  • Ruano, Ana
  • Motilva, María-José
  • Bartolomé, Begoña
  • Moreno-Arribas, M. Victoria
Sulfites are widely used in the wine industry, but their human health effects remain debated. This study is the first to investigate the interaction between wine sulfites and gut microbiota under simulated gastrointestinal conditions. Using the simgi model, red and synthetic wines─with and without SO2 (200 mg/L)─underwent gastrointestinal digestion and colonic fermentation with fecal microbiota from three healthy donors (n = 3). SO2-treated wines slightly modified gut microbiota composition, decreasing beneficial bacteria like Bacteroides and Ruminococcus, while increasing Coprococcus and pro-inflammatory Escherichia/Shigella, although the overall microbiome of each individual seems to condition its resilience toward SO2. These effects were partially mitigated in red wine, suggesting a protective role of wine polyphenols. Additionally, SO2 treatment in red wines enhanced phenolic metabolism at the gut level, increasing low-molecular-weight phenolic compounds, such as valerolactones, bioavailable in the small intestine and colon. For instance, 5-(3′,4′-dihydroxyphenyl)-γ-valerolactone concentrations were consistently higher in SO2-treated red wine (0.86–1.28 mg/L) than in the untreated wine (<0.78 mg/L) after 6 h of fermentation. This pioneering study reveals a complex interplay between sulfites, wine components, and gut microbiota, with potential health implications, especially for sulfite-sensitive individuals., N.M. thanks to Spanish Ministry of Science and Innovation (Spain) for the “Juan de la Cierva” Grant (FJC2021-046862-I). This work was funded by the Spanish Government Grant PID2023-148419OB-I00 and FIVIN-OIVE., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fecal fermentation of human ileal fluid after mango intake impacts on colonic microbiota and microbial (poly)phenol catabolism

  • Cáceres-Jiménez, Salud
  • Molinero, Natalia
  • Cueva, Carolina
  • Dobani, Sara
  • Pourshahidi, Kirsty L.
  • Gill, Chris I.R.
  • Tuohy, Kieran M.
  • Moreno-Rojas, José Manuel
  • Crozier, Alan
  • Bartolomé, Begoña
  • Moreno-Arribas, M. Victoria
  • Pereira-Caro, Gema
Data will be made available on request., Mango (Mangifera indica L.) comprises a rich source of (poly)phenolic compounds, predominantly galloyl-derived (poly)phenols. While a portion of these bioactive compounds are metabolised and absorbed in the upper gastrointestinal tract, the remainder reach the colon, where they are subjected to microbial catabolism. This study investigated the colonic transformation of mango (poly)phenols and their impact on gut microbiota. Ileal fluids (IFs), collected from six ileostomists before and for an 8 h period after mango consumption, were subjected to ex vivo fecal fermentation to simulate colonic conditions. Pre-fermentation (0 h) and post-fermentation (2, 6 and 24 h) samples were analysed by UHPLC-HRMS for changes in (poly)phenol composition, by GC-FID for microbial metabolism (short-chain fatty acids (SCFAs)), and 16S rRNA gene sequencing to assess changes in gut microbiota. A total of 48 phenolics were identified in the fermented IF samples, before and after mango consumption. The main compounds included benzoic acids, hydroxybenzenes and galloyl derivatives, with high interindividual variability. Among the microbial catabolites, 3,4,5-trihydroxybenzoic acid, 3,5-dihydroxy-4-methoxybenzoic acid and 1,3,5-trihydroxybenzene emerged as possible discriminants of fermented mango IFs. The IF matrix, rather than mango (poly)phenols, significantly influenced gut bacterial diversity (p < 0.05, alpha-diversity) and increased microbial SCFAs production (mainly acetic, butyric and propionic acids). A significant positive correlation (p < 0.05) was found between characteristic catabolites in fermented mango IF samples and some commensal and healthy-related bacteria such as Bifidobacterium spp. Overall, despite high interindividual variability, the results suggest that IF-enriched with mango (poly)phenols undergo substantial microbial catabolism and positively impact on the gut microbial environment., This study was funded by the European Regional Development Funds (ERDF), the Spanish Ministry of Science, Innovation and Universities (MCIU) and the Spanish State Research Agency (AEI) through the projects “Bioavailability of mango polyphenols in healthy and ileostomy patients: relevance of the bioactive forms in vivo on the gastrointestinal health” (RTI2018–096703-J-I00) and PID2023-148419OB-I00. S.C.-J. is supported by a predoctoral fellowship funded by the Spanish Ministry of Science, Innovation and Universities (FPU20/03549). A.C. and C.I.R.G. were funded by the Distinguished Scientist Fellowship Program of King Saud University, Riyadh, Saudi Arabia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gut microbiota and nutrition in nursing homes: Challenges and translational approaches for healthy aging

  • Jiménez Arroyo, Cristina
  • Molinero, Natalia
  • Moreno-Arribas, M. Victoria
The growing aging population is leading to an increase in demand for long-term care. This is particularly true in nursing homes, where residents are exposed to various challenges such as immunosenescence, frailty, multimorbidity, and dietary and environmental constraints. These interrelated factors contribute to gut microbiota alterations, underscoring the need for tailored strategies to preserve health and resilience in a long-term care setting. Despite its recognized relevance in healthy aging, the gut microbiome of institutionalized elderly remains markedly understudied. This review provides a comprehensive report of the current evidence on the interplay between diet, gut microbiota, and aging among nursing-home residents. The available literature suggests that both aging and institutional living contribute to a less favorable microbiome profile, and several contributing factors, many of them dietary, have been identified. Altered gastrointestinal physiology, malnutrition, and other common conditions in residential care, such as functional or cognitive impairments, frequently lead to changes in food intake that affect the gut ecosystem. Decline in immune system, increased infection risk, sarcopenia, cognitive deterioration, and high medication burden have also been linked to microbiota disruptions in this population. Importantly, adjusting several modifiable features of institutional care, particularly those related to diet and lifestyle, may help counteract these effects by supporting gut health. We further examine how appropriate nutritional strategies can positively influence gut microbiota composition and function, offering a pathway to promote resilience and functionality even in the presence of geriatric syndromes. In addition to identifying these challenges, this review outlines feasible, microbiota-informed strategies to improve quality of life and health outcomes. These include individualized dietary adaptations, targeted supplementation, physical activity interventions, and the integration of digital and artificial intelligence tools to support personalized nutrition. Finally, we highlight the need for standardized protocols and implementation science frameworks to enhance clinical translation, thereby advancing an integrative and as yet underrepresented perspective on microbiota-based strategies to promote healthier aging trajectories in institutionalized elderly., The authors acknowledge funding from the Spanish Ministry of Science, Innovation, and Universities (Project PID2023-148419OB-I00, MICIN)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human gut microbiome study through metagenomics: Recent advances and challenges for clinical implementation, Estudio del microbioma intestinal humano mediante metagenómica: avances recientes y desafíos para su implementación clínica

  • Jiménez Arroyo, Cristina
  • Molinero, Natalia
  • Campo, Rosa del
  • Delgado, Susana
  • Moreno-Arribas, M. Victoria
[EN] Metagenomics has decisively advanced the study of the gut microbiome, enabling a better understanding of its importance for human health. Metataxonomics, based on the sequencing of the 16S rRNA gene, provides taxonomic profiles of prokaryotes, while shotgun metagenomics allows a comprehensive characterization of all DNA present in a sample. With adequate sequencing depth, the latter increases taxonomic resolution to the strain level and provides detailed information on the functional potential of the microbiota. However, the lack of standardization in sample collection and processing, sequencing technologies, and data management limits the comparability of results and their implementation in clinical laboratories. This review offers a practical and updated framework on metagenomic methodologies, data analysis, and the application of artificial intelligence tools, highlighting advances and best practices to facilitate the integration of functional microbiome analysis into clinical practice and to overcome current challenges., [ES] La metagenómica ha impulsado de manera decisiva el estudio del microbioma intestinal, lo que ha permitido comprender su importancia para la salud humana. La metataxonómica, basada en la secuenciación del gen del ARNr 16S, ofrece perfiles taxonómicos de procariotas, mientras que la metagenómica shotgun permite una caracterización más completa de todo el ADN presente en la muestra. Con una profundidad de secuenciación adecuada, esta última amplía la resolución taxonómica hasta el nivel de cepa y proporciona información detallada sobre el potencial funcional de la microbiota. Sin embargo, la falta de estandarización en la recolección y procesamiento de muestras, las tecnologías de secuenciación, y la interpretación y gestión de los datos, limita la comparación de resultados y su implementación en laboratorios clínicos. Esta revisión ofrece un marco práctico y actualizado sobre las metodologías metagenómicas, el análisis de datos y el uso de inteligencia artificial, destacando avances y buenas prácticas para facilitar su integración en la práctica médica y superar los desafíos actuales., The authors are grateful for the funding received from the Spanish Ministerio de Ciencia, Innovación y Universidades (MICIN) [Ministry of Science, Innovation and Universities] (Project PID2023-148419OB-I00, MICIN). We are grateful for the support of the Red Científica Conexión [Scientific Network Connection]-MICROBIOMA, funded by the Consejo Superior de Investigaciones Científicas (CSIC) [Spanish National Research Council], as well as the MIDAS Network (RED2022-134934-T) funded by MICIN., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

The simgi® Simulator and COST INFOGUT: Towards Harmonized complex In vitro Colon Models

  • Cueva, Carolina
  • Diego de la Serna, Raquel de
  • Roldán García, Mikel
  • Molinero, Natalia
  • Bartolomé, Begoña
  • Moreno-Arribas, M. Victoria
Trabajo presentado al 1st INFOGUT Annual Meeting, celebrado del 26 al 28 de mayo de 2025 en Bologna (Italia)., The authors gratefully acknowledge funding from the Spanish Ministry of Science (grants EQC2019-005402-P and PID2023-148419OB-I00), and the EU (PlasticsFatE and PRIMA InnSol4Med projects)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Micro- and nanoplastics, metagenomics, and food systems: toward an integrated perspective

  • Lemos Junior, Wilson J.F.
  • Moreno-Arribas, M. Victoria
Micro- and nanoplastics (MNPs) are increasingly embedded across food systems, from soils and aquaculture to food-contact materials and processed products, raising concerns about their impact on the gut microbiome. Ingestion is now a recognized exposure route, with particles found in foods and in human stools, blood, and other tissues. Their small size, heterogeneous chemistry, and capacity to carry additives and pollutants enable close interactions with gut epithelia and resident microbes. Multi-omics studies show that MNPs alter community structure, enrich stress-tolerant taxa, disrupt functional pathways, and can act as vectors for antibiotic resistance genes and mobile elements. Gut consortia also harbor enzymes capable of degrading synthetic polymers, though the physiological implications remain unclear. Food matrices, diet, and co-exposure to additives further modulate MNP fate and bioavailability. This perspective integrates metagenomic evidence and highlights how multi-omics, Artificial Intelligence (AI), and advanced models can inform One Health–aligned risk assessment and guide safer, more sustainable food systems., The work in progress in our laboratory is partially supported by the Spanish Ministry of Science and Innovation (Spain), grant number PID2023-148419OB-100, the Community of Madrid (Grant number 2025-T1/BIO 36296), and by the European Union’s Horizon 2020, Grant Agreement number 965367 (PlasticsFatE). The authors thank CSIC Interdisciplinary Thematic Platform for Sustainable Plastics toward a Circular Economy (PTI+ SusPlast)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Multinutrient Fortasyn Connect Influences Gut Microbiota and Intestinal Function in Early Alzheimer’s Disease

  • Molinero, Natalia
  • Montero-Atalaya, Marta
  • Méndez, Lucía
  • Roldán, Mikel
  • Palmí Cortés, Irene
  • Ruhland, Sara
  • Bartolomé, Begoña
  • Medina, Isabel
  • Moreno-Arribas, M. Victoria
Nutritional supplementation is emerging as a promising strategy to support clinical management of early Alzheimer’s disease (AD), partly through modulation of the intestinal microbiome via the microbiota-gut-brain axis. This study investigated the impact of Fortasyn Connect (Souvenaid®), a multinutrient formulation, on gut microbiota using a dual approach: i) a dynamic gastrointestinal simulator (simgi®) inoculated with feces from AD patients, and ii) an observational study involving early-stage AD patients (n = 22) receiving or not the supplement. The in vitro model provided a direct, host-independent assessment of microbiota responses, showing increased Bifidobacterium and Lactobacillus levels, alongside enhanced short-chain fatty acid (SCFA) production. In patients, supplementation was associated with higher fecal abundance of Bifidobacterium and Christensenellaceae, reduced inflammatory markers (calprotectin and myeloperoxidase), and increased butyrate levels. Fecal lipidomic and proteomic analyses indicated improved lipid digestion, increased secretory IgA, and modulation of host proteins linked to gut-brain homeostasis. Systemically, elevated levels of iron, folate, and vitamin B12 were also observed. For the first time, this study shows that supplements such as Fortasyn Connect can beneficially modulate the gut ecosystem and related immune-metabolic pathways in early AD, thereby targeting disease-relevant mechanisms through the gut-brain axis, in the context of aging, Research in our laboratory was supported by Grants PID2023-148419OB-100 (Spanish Ministry of Science, Innovation and Universities) and 2024AEP090 (CSIC), as well as by the Juan de la Cierva contract FJC2021-046862-I (N.M.) and the predoctoral contract PRE2020-093312 (M. M.-A.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Shrimp by-product-derived astaxanthin modulates gut microbiota composition and proteolytic metabolism: valorization of a sustainable bioactive ingredient

  • Roldán García, Mikel
  • Čagalj, Martina
  • Šolto, Toni Jurić
  • Relaño de la Guía, Edgard
  • Molinero, Natalia
  • Cueva, Carolina
  • Šimat, Vida
  • Moreno-Arribas, M. Victoria
Astaxanthin is a bioactive carotenoid of growing interest as a functional food ingredient, yet its recovery from sustainable sources and its interactions with the gut microbiota remain insufficiently characterized. In this study, astaxanthin-rich extracts were recovered from shrimp by-products (Parapenaeus longirostris) through ultrasound-assisted extraction and subjected to detailed chemical characterization by HPLC and UPLC-ESI-TQ-MS, confirming astaxanthin as the predominant carotenoid (80.4% of the quantified fraction) alongside a defined isomeric profile. To assess the biological activity of this ingredient at the colonic level, physiologically relevant concentrations were tested in in vitro colonic fermentations inoculated with fecal microbiota from three healthy human donors, enabling the capture of interindividual variability. Microbial dynamics were assessed by 16S rRNA gene sequencing and culture-based methods, and functional responses were determined through short-chain fatty acid and ammonium production. Astaxanthin supplementation induced donor-dependent responses, with health-associated genera including Bifidobacterium, Faecalibacterium, Roseburia, and Coprococcus increasing in responsive donors, while potentially pro-inflammatory taxa such as Escherichia–Shigella, Bilophila, and Desulfovibrio decreased. Functionally, astaxanthin attenuated proteolytic metabolism, evidenced by reduced ammonium and branched-chain fatty acid levels, suggesting a selective shift toward a more saccharolytic and metabolically favorable microbial profile. Overall, shrimp-derived astaxanthin acts as a selective modulator of gut microbial metabolism in a microbiota-dependent manner, and these findings support the valorization of crustacean by-products as a sustainable source of bioactive astaxanthin with promising applications in gut health-oriented ingredients., This work was supported by the PRIMA Programme under project InnoSol4Med (Project ID 1836) supported by the European Union, with co-funding from the Croatian Ministry of Science and Education and the Spanish Misnistry of Science, Innovation and Universities (PID2023-148419OB-I00)., Peer reviewed
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Potential risk to brain health after surgical interventions: biomarkers to predict the occurrence of cognitive decline

  • Rey-Picazo, Julio
  • Pita, Jimena
  • Peña, Lucía, 0000-0001-5237-4619
  • Ferraz Torres, Marta
  • Martínez García, Óscar
  • Ávila-Villanueva, Marina
  • Santos-Pérez, Gloria
  • López-Sanz, David
  • Moreno-Arribas, M. Victoria
  • González Perrino, Carlos
  • Muedra, Vicente
  • Miñano-Molina, Alfredo Jesús
  • Hernández-Rabaza, Vicente
  • Gómez-Pinedo, Ulises
  • León-Espinosa, Gonzalo
As the global population ages, the number of people living with dementia is projected to increase significantly. Estimations indicate that over 150 million people worldwide will be living with dementia by 2050, with Alzheimer’s disease being the most common cause. Elderly people are also at greater risk of undergoing surgery, either elective or emergency, escalating the associated likelihood leading to cognitive decline, especially if accumulative. However, the relationship between surgery and dementia development remains controversial. The cause seems to lie in the heterogeneous preoperative state of subjects participating in research studies. Interpreting and comparing the results of these studies could be an arduous task due to variables such as medication, followup time, type of surgery and anesthesia, duration and invasiveness of the surgical intervention, differential neuroinflammatory response, the patient metabolic/biochemical status or if there are comorbidities. Considering the complexity of this type of studies, the present review summarizes the most important factors/biomarkers that could provide useful information for pre- and post-operative medical decision making in relation to the development of dementia. Emphasis will be placed on the relationship between temperature, Tau phosphorylation, whose plasma detection as an early diagnostic factor is gaining great relevance, and other neurodegenerative biomarker interplay. The prolonged maintenance of key biomarkers in blood could be detrimental and, therefore, a more comprehensive individualized hospital study may improve the prevention of postoperative complications., This work was supported by Grant PID2023-148419OB100 from the Spanish Ministry of Science, Innovation and Universities.